Comparative Study
doi: 10.1128/AAC.25.4.504.
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens
- PMID: 6732220
- PMCID: PMC185564
- DOI: 10.1128/AAC.25.4.504
Item in Clipboard
Comparative Study
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens
Antimicrob Agents Chemother.
1984 Apr.
Abstract
A comparison was made of the in vitro activity of ciprofloxacin (Bay o 9867) with nine other antibiotics against isolates of Campylobacter jejuni, Salmonella spp., Shigella spp., Yersinia enterocolitica, Clostridium difficile, Vibrio spp., and Escherichia coli. Minimum inhibitory concentrations of ciprofloxacin were the lowest of any compound tested for all organisms except C. difficile.
Similar articles
-
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.Drugs Exp Clin Res. 1985;11(4):253-7. Drugs Exp Clin Res. 1985. PMID: 2941257
-
Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia.Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):73-80. doi: 10.2478/prilozi-2019-0017. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019. PMID: 31605592
-
In vitro activity of lomefloxacin and other antimicrobials against bacterial enteritis pathogens.Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):339-43. doi: 10.1016/0732-8893(92)90020-t. Diagn Microbiol Infect Dis. 1992. PMID: 1319301
-
Antimicrobial susceptibility testing of bacteria that cause gastroenteritis.Clin Lab Med. 2015 Jun;35(2):313-31. doi: 10.1016/j.cll.2015.02.005. Epub 2015 Apr 4. Clin Lab Med. 2015. PMID: 26004645 Review.
-
Animal and In Vitro Models as Powerful Tools to Decipher the Effects of Enteric Pathogens on the Human Gut Microbiota.Microorganisms. 2023 Dec 29;12(1):67. doi: 10.3390/microorganisms12010067. Microorganisms. 2023. PMID: 38257894 Free PMC article. Review.
Cited by
-
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.Antimicrob Agents Chemother. 1989 Aug;33(8):1385-7. doi: 10.1128/AAC.33.8.1385. Antimicrob Agents Chemother. 1989. PMID: 2802563 Free PMC article.
-
Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.Pharm Weekbl Sci. 1986 Feb 21;8(1):1-21. doi: 10.1007/BF01975473. Pharm Weekbl Sci. 1986. PMID: 3515312 Review.
-
Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.Antimicrob Agents Chemother. 1989 Jul;33(7):1101-4. doi: 10.1128/AAC.33.7.1101. Antimicrob Agents Chemother. 1989. PMID: 2675757 Free PMC article. Clinical Trial.
-
Use of quinolones in the treatment of gastrointestinal infections.Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):325-9. doi: 10.1007/BF01967006. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1864292 Review.
-
Quinolones in the treatment of acute bacterial diarrhoeal diseases.Drugs. 1993;45 Suppl 3:114-8. doi: 10.2165/00003495-199300453-00019. Drugs. 1993. PMID: 7689441 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
